Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Adelphi delivers insight-led multi-perspective solutions, optimising healthcare interventions and brand developments throughout the lifecycle. Services across strategic marketing, marketing and business intelligence, real-world observational research, disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product development consultancy.
A+A Research is a fast growing dynamic company, offering a broad range of services that includes full service product and project support: from preparatory market research in the early clinical phases, to defining the needs-profile and product positioning, and extend through to launch and beyond to continuous monitoring in the market.
Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30 years’ sector experience. Driven by a fervent curiosity and boundless resourcefulness, we specialise in getting to the heart of our clients’ business challenges. Our custom research is designed to delve deeper, beyond post-rationalisation, to uncover what’s really going on in healthcare.
Evaluate is the trusted provider of commercial intelligence including product sales and consensus forecasts to 2022 for commercial teams and their advisors within the global life science industry. We help our clients make high value decisions through superior quality, timely, must-have data and insights, combined with personalised, expert client support. Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Our Custom Services group delivers project based analytical and data services. EP Vantage, our independent, award-winning editorial team, offers data-driven, forward-looking news, commentary and analysis on a daily basis. For more information, please visit: www.evaluategroup.com. On Twitter: @evaluatepharma, @evaluatemedtech, @evaluateJP, @epvantage. On Instagram: Evaluateltd.
In an era of breakneck change and low tolerance for missed or misread opportunities, businesses need reliable, astute guidance to shape markets — not merely respond to them. Now entering our second century of leadership in applied marketing science, NAXION guides shrewd, confident business decisions based on an exceptional integration of advanced research methods and target industry perspectives.
PLAMED Asia is your one-stop source for high-quality, seamless, online fieldwork services with healthcare professionals in Asia. The PLAMED Asia Panel was born through a collaboration between leading healthcare research companies in Asia. We are conscious of our responsibilities to both the physician community and our clients, and those dual responsibilities are reflected both in the origin of our name, and in our mission statement.
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. From our offices in Philadelphia, London and Singapore we provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
What is the market potential of your product? How should you position your device to physicians, patients or caregivers? Which product features should you leverage in your communication strategy? Our healthcare industry specialists provide answers to these and similar questions for the healthcare, pharmaceutical, biotechnology and medical device industries.